Back to Rankings

REPL

Replimune GroupD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
REPL vs peer average
34/100
REPL vs. peer average (D vs. C)
Grade spread
B 3 · C 5 · D 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ADCT is the first available peer comparator.

Same-sector small-cap biotech peer used only for size and event-volatility context; the packet does not establish it as a direct operating comparable.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerADCTADC Therapeutics
REPL
Replimune Group
ADCT
ADC Therapeutics
Grade
D
C
Momentum
99
8
Value
41
41
Sentiment
0
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs ADCT

REPL / ADCT
Grade Position
Below peers
REPL vs. peer average (D vs. C)
34/100
Momentum
99
REPL
Value
41
REPL
Sentiment
0
ADCT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs REPL
1
ADCT
ADCT
C
60/100
-1
2
NGNE
NGNE
D
40/100
Even
3
SGMT
SGMT
B
80/100
-2
4
LBRX
LB Pharmaceuticals Inc Common
C
60/100
-1
5
SANA
Sana Biotechnology Inc Common
D
40/100
Even
ADCT is the first peer returned for this comparison set.